Compound name
Sunitinib
Alt Name
GSK-R
sunitinibum
Sutent
SU-11248
Compound Image
Sunitinib.png
SMILES
CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
MW
398.47
Brutto
C22H27FN4O2
InChI
InChI=1S/C22H27FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12-
InChI Key
WINHZLLDWRZWRT-ATVHPVEESA-N
Approval Jurisdiction
2006 FDA
Approved for clinical use
Renal Cancer, Imatinib Resistant GIST
CAS
341031-54-7
PubChem CID
5329102
Action
RTK, Multiple Tyrosine Kinases Targeted
Approved Drug List
1
Commercial Vendor
Sugen/Pfizer
Reference 2